Our client was the founder and CEO of a biotechnology company. He learned that the Board intended to take the company public in six months, and the company’s complex structure meant that compensation talks would be equally complicated. Going in alone or uneducated could mean not only getting a bad deal for himself, but also not understanding how it would impact the company he created. Please see disclosures at the end of this brief.
Ballentine Partners, LLC | 781-314-1300 | [email protected]
© Copyright 2021 Ballentine Partners, LLC. All rights reserved.
FOR DETAILS OF HOW ANY SURVEYS REFERENCED ABOVE WERE CONSTRUCTED, PLEASE REFER TO OUR DETAILED DISCLOSURES IN EACH LISTING. THE SURVEYS DO NOT IMPLY ANYTHING ABOUT A PARTICULAR CLIENT'S EXPERIENCE OR INVESTMENT RESULTS WITH BALLENTINE PARTNERS.